Tuesday, 12 May 2020

India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug

India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...

from NDTV News - Topstories https://ift.tt/3bqUqQ1
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Father Stabs Son, 10, To Death After Fight Over Playing In Rain In Delhi: Cops

A 10-year-old boy was allegedly stabbed to death by his father on Sunday afternoon following a dispute over playing in the rain in Sagarpur ...